Kazia Therapeutics ( ($KZIA) ) just unveiled an update. On October 2, 2025, Kazia Therapeutics announced an 86% reduction in tumor burden in a ...

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today reported a substantial reduction in tumor burden from a single-patient expanded access case in ...

Kazia Therapeutics (KZIA) reported a substantial reduction in tumor burden from a single-patient expanded access case in triple-negative breast ...

Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a ...

The White House is investing $50 million to explore possible uses of AI in pediatric cancer research? Great. But how about ...

Intensity-modulated radiation therapy did not increase the risk for feeding tube dependence for patients with oropharyngeal ...

Researchers at the University of Vienna have developed fluorescent peptide tracers that can simultaneously visualize and ...

The discovery of a defensive mechanism could help stop cancer before it spreads. Cancer cells rapidly increase their energy output when physically squeezed, according to a study in Nature ...

Scientists have found a way to supercharge the immune system’s T cells by blocking a protein called Ant2, essentially rewiring how these cells generate energy. This metabolic reprogramming makes them ...

A drug that costs 5p per tablet and is already widely used to treat malaria may also cut the chances of breast cancer ...

Researchers at University of Tsukuba have identified genes and signaling pathways that trigger the death of individual ...

The emergence of drug resistance remains one of the greatest challenges in effective cancer therapy. Despite advances in ...